Figure 1From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitroA. OCUM-2MD3 cell (Phase contrast microscope × 400); B. OCUM-2MD3/L-OHP cell (Phase contrast microscope × 400); C. OCUM-2MD3 cell (TEM × 5000); D. OCUM-2MD3/L-OHP cell (TEM × 5000).Back to article page